Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma

Clinical trial NCT01842308 · COMPLETED

Trial details

NCT number: NCT01842308
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

DS Stage I Plasma Cell Myeloma DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Start date: 2013-06-04
Primary completion: 2017-10-11
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.